CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC

NCT04097444 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

BIOLOGICAL: Bevacizumab
DRUG: 5-fluorouracil
DRUG: Leucovorin calcium
DRUG: Irinotecan hydrochloride
DRUG: Oxaliplatin
DRUG: Capecitabine

Sponsor

Chugai Pharmaceutical